• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬血清中微小RNA的稳定性——肿瘤诊断中用作生物标志物的先决条件

Stability of microRNAs in Canine Serum-A Prerequisite for Use as Biomarkers in Tumour Diagnostics.

作者信息

Kehl Alexandra, Klein Ruth, Steiger Katja, Aupperle-Lellbach Heike

机构信息

Laboklin GmbH&Co. KG, 97688 Bad Kissingen, Germany.

School of Medicine, Institute of Pathology, Technical University of Munich, 81675 München, Germany.

出版信息

Vet Sci. 2025 Apr 21;12(4):390. doi: 10.3390/vetsci12040390.

DOI:10.3390/vetsci12040390
PMID:40284892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12031383/
Abstract

Since microRNAs are released into the bloodstream and miRNA profiles are supposed to differ between healthy and tumour patients, miRNAs seem to have potential as biomarkers. An essential prerequisite for biomarkers in a routine diagnostic setup is their stability in serum over time. In this study, serum samples from 10 healthy dogs were analysed at different time points and under various temperature conditions (after 24 and 48 h, at 4° or 20 °C) for the copy number of eight miRNAs (miR-20b, 21, 122, 126, 192, 214, 222, 494) using ddPCR. The miR-21 had the highest copy number, whereas miR-494 had the lowest copy number in canine blood samples. The values of each miRNA varied individually between the dogs, showing a 5 to 10-fold range. Stability differed between the miRNAs, with miR-192 having the best stability. The copy number of miR-20b, miR-126 and miR-214 decreased not significantly during 48 h storage time. In contrast, miR-21, miR-122 and miR-222 were stable for 24 h only but decreased significantly after 48 h. The (in)stability of individual canine miRNAs must be considered when transferring study results into veterinary routine diagnostics, as the transport and storage conditions are variable. As far as possible, standardisation of sampling, storage and quantification of miRNAs is needed.

摘要

由于微小RNA会释放到血液中,而且健康患者和肿瘤患者的微小RNA谱理应不同,因此微小RNA似乎有作为生物标志物的潜力。在常规诊断设置中,生物标志物的一个基本前提条件是其在血清中随时间的稳定性。在本研究中,使用数字液滴聚合酶链反应(ddPCR)在不同时间点和各种温度条件下(24小时和48小时后,4°C或20°C)分析了10只健康犬的血清样本中8种微小RNA(miR-20b、21、122、126、192、214、222、494)的拷贝数。在犬类血液样本中,miR-21的拷贝数最高,而miR-494的拷贝数最低。每只犬的每种微小RNA的值各不相同,显示出5至10倍的范围。不同微小RNA的稳定性有所不同,其中miR-192的稳定性最佳。在48小时的储存时间内,miR-20b、miR-126和miR-214的拷贝数没有显著下降。相比之下,miR-21、miR-122和miR-222仅在24小时内稳定,但在48小时后显著下降。在将研究结果应用于兽医常规诊断时,必须考虑单个犬类微小RNA的(不)稳定性,因为运输和储存条件是可变的。尽可能需要对微小RNA的采样、储存和定量进行标准化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247e/12031383/4d8a7c9e0ac1/vetsci-12-00390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247e/12031383/3b0cb7a32fa9/vetsci-12-00390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247e/12031383/4d8a7c9e0ac1/vetsci-12-00390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247e/12031383/3b0cb7a32fa9/vetsci-12-00390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/247e/12031383/4d8a7c9e0ac1/vetsci-12-00390-g002.jpg

相似文献

1
Stability of microRNAs in Canine Serum-A Prerequisite for Use as Biomarkers in Tumour Diagnostics.犬血清中微小RNA的稳定性——肿瘤诊断中用作生物标志物的先决条件
Vet Sci. 2025 Apr 21;12(4):390. doi: 10.3390/vetsci12040390.
2
Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.循环血液中微小RNA的稳定性——分析前的方法学考量
PLoS One. 2017 Feb 2;12(2):e0167969. doi: 10.1371/journal.pone.0167969. eCollection 2017.
3
Evaluation of microRNA stability in feces from healthy dogs.健康犬粪便中微小RNA稳定性的评估。
Vet Clin Pathol. 2018 Mar;47(1):115-121. doi: 10.1111/vcp.12566. Epub 2018 Feb 2.
4
Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.犬非传染性炎症性中枢神经系统疾病患者血清和脑脊液中 microRNA 谱分析的挑战与标准化。
Acta Vet Scand. 2019 Dec 3;61(1):57. doi: 10.1186/s13028-019-0492-y.
5
Systematic analysis of different degrees of haemolysis on miRNA levels in serum and serum-derived extracellular vesicles from dogs.系统分析不同程度溶血对犬血清和血清衍生细胞外囊泡中 miRNA 水平的影响。
BMC Vet Res. 2022 Sep 22;18(1):355. doi: 10.1186/s12917-022-03445-8.
6
Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer.非外泌体和外泌体来源的微小RNA作为犬乳腺癌中有前景的生物标志物
Life (Basel). 2022 Apr 1;12(4):524. doi: 10.3390/life12040524.
7
Evaluation of microRNA Stability in Plasma and Serum from Healthy Dogs.健康犬血浆和血清中微小RNA稳定性的评估
Microrna. 2017;6(1):42-52. doi: 10.2174/2211536606666170113124114.
8
Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome.循环微小RNA作为犬库欣氏综合征的非侵入性生物标志物
Front Vet Sci. 2021 Nov 17;8:760487. doi: 10.3389/fvets.2021.760487. eCollection 2021.
9
miRNA Profiles of Canine Intestinal Carcinomas, Lymphomas and Enteritis Analysed by Digital Droplet PCR from FFPE Material.利用数字液滴PCR对福尔马林固定石蜡包埋材料进行分析的犬肠道癌、淋巴瘤和肠炎的微小RNA谱
Vet Sci. 2023 Feb 6;10(2):125. doi: 10.3390/vetsci10020125.
10
miRNA profiles of canine cutaneous mast cell tumours with early nodal metastasis and evaluation as potential biomarkers.犬皮肤肥大细胞瘤早期淋巴结转移的 miRNA 谱分析及其作为潜在生物标志物的评估。
Sci Rep. 2020 Nov 3;10(1):18918. doi: 10.1038/s41598-020-75877-x.

本文引用的文献

1
Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study.全因性和特定病因癌症中血浆循环微小RNA的失调:鹿特丹研究
Biomark Res. 2024 Aug 13;12(1):83. doi: 10.1186/s40364-024-00626-5.
2
Cell-free and extracellular vesicle microRNAs with clinical utility for solid tumors.具有实体瘤临床应用价值的无细胞和细胞外囊泡微小RNA
Mol Oncol. 2024 Aug 11. doi: 10.1002/1878-0261.13709.
3
Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future.分子生物标志物在犬猫肿瘤学中的临床应用:现状与未来
Vet Sci. 2024 May 2;11(5):199. doi: 10.3390/vetsci11050199.
4
Review of Molecular Technologies for Investigating Canine Cancer.用于研究犬类癌症的分子技术综述
Animals (Basel). 2024 Feb 29;14(5):769. doi: 10.3390/ani14050769.
5
MicroRNA-126 in dogs with immune complex-mediated glomerulonephritis.犬免疫复合物介导性肾小球肾炎中的 microRNA-126。
J Vet Intern Med. 2024 Jan-Feb;38(1):216-227. doi: 10.1111/jvim.16932. Epub 2023 Dec 20.
6
miRNA Profiles of Canine Intestinal Carcinomas, Lymphomas and Enteritis Analysed by Digital Droplet PCR from FFPE Material.利用数字液滴PCR对福尔马林固定石蜡包埋材料进行分析的犬肠道癌、淋巴瘤和肠炎的微小RNA谱
Vet Sci. 2023 Feb 6;10(2):125. doi: 10.3390/vetsci10020125.
7
Association of fecal and serum microRNA profiles with gastrointestinal cancer and chronic inflammatory enteropathy in dogs.粪便和血清 microRNA 谱与犬胃肠道癌和慢性炎症性肠病的关联。
J Vet Intern Med. 2022 Nov;36(6):1989-2001. doi: 10.1111/jvim.16530. Epub 2022 Sep 19.
8
Stability of circulating microRNAs in serum.血清中循环微RNA的稳定性
PLoS One. 2022 Aug 31;17(8):e0268958. doi: 10.1371/journal.pone.0268958. eCollection 2022.
9
Recommendations on qPCR/ddPCR assay validation by GCC.GCC 关于 qPCR/ddPCR assay 验证的建议。
Bioanalysis. 2022 Jun;14(12):853-863. doi: 10.4155/bio-2022-0109. Epub 2022 Jun 15.
10
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy.一种基于血液的微小RNA特征对接受免疫治疗的晚期非小细胞肺癌总生存期具有预后价值。
NPJ Precis Oncol. 2022 Mar 31;6(1):19. doi: 10.1038/s41698-022-00262-y.